Dystrophic Epidermolysis Bullosa

This is a type of epidermolysis bullosa, which is a group of skin disorders. It causes the skin to blister easily and severely, even from minor bumps or friction. The blisters often heal with scars and changes in the nails. It's usually present from birth or early childhood and can be inherited in different ways.

Condition

What people with Dystrophic Epidermolysis Bullosa report

Every report comes from a Lived member, sent anonymously.

Have you had Gastrostomy for Dystrophic Epidermolysis Bullosa?

NameHow it went

About Dystrophic Epidermolysis Bullosa

What It Is

Dystrophic epidermolysis bullosa (DEB) is an inherited condition that makes the skin so fragile it blisters or tears with ordinary friction, such as rubbing from clothing, a bump or being lifted. The damage happens in the deeper layer of the skin, so blisters and open wounds heal with scarring and tiny white bumps called milia. Fingernails and toenails are often thickened, misshapen or lost. DEB ranges widely in severity. In its milder forms, blistering mostly affects the hands, feet, knees and elbows, and in some people abnormal nails are the only sign. In the severe recessive form, babies are often born with widespread blisters and missing skin. Over time, repeated wounds and scarring can affect the mouth, the esophagus (the tube that carries food to the stomach), the eyes and the hands. DEB is one of several types of epidermolysis bullosa (EB), and it is rare: an estimated 3 people per million have it.

Causes & Risk Factors

DEB is caused by changes in the COL7A1 gene, which carries the instructions for type VII collagen. This protein forms the anchoring fibrils that fasten the top layer of skin to the layer beneath it. When it is missing or faulty, the layers separate easily under friction or minor injury. Friction, heat and pressure bring on new blisters, but they do not cause the condition. Generally, the less working collagen a person makes, the more severe the disease. There are two inheritance patterns. In dominant DEB, one altered copy of the gene is enough to cause the condition, and each child of an affected parent has a 50% chance of inheriting it. About 30% of people with dominant DEB are the first in their family, because the gene change arose new in them. In recessive DEB, a person inherits an altered copy from each parent. The parents are usually unaffected carriers, and each of their children has a 25% chance of having the condition.

How It's Diagnosed

EB is usually suspected when a baby or child has blisters that appear with minimal rubbing, along with scarring or nail changes. At birth it is often impossible to tell from appearance alone which type of EB a child has, or how severe it will be, so testing matters. In the United States, most experienced EB clinicians start with genetic testing from a blood or saliva sample, which looks for changes in COL7A1 and other genes linked to fragile skin. Finding the specific variant confirms DEB and shows whether it is dominant or recessive. Testing the parents often helps, especially when no one else in the family is affected. A skin biopsy, in which a small sample of freshly blistered skin is examined under special microscopes, can be used when genetic results are unclear or testing is not available. Knowing the exact genetic change helps with planning care, judging whether a treatment applies, and genetic counseling. Once the family's variant is known, relatives can be tested, and testing during a future pregnancy or before embryo transfer during in vitro fertilization (IVF) becomes possible.

Treatment Options

There is no cure for DEB, but care can reduce new damage, help wounds heal and prevent or treat complications. The foundation is careful daily skin care: gentle handling, padding over bony areas, soft loose clothing and well-fitting shoes, and avoiding adhesive tape and heat on the skin. New blisters are usually lanced and drained so they do not spread, then covered with non-stick dressings and padding. Infections are treated with antiseptics or antibiotics, and pain and itch with topical and oral medicines and psychological support. Three treatments approved by the US Food and Drug Administration (FDA) since 2023 aim at the wounds themselves. Beremagene geperpavec (Vyjuvek) is a topical gene therapy: a modified herpes simplex virus delivers working copies of the COL7A1 gene into wound cells. A gel is applied to selected wounds once a week, in a clinic or at home by a trained patient or caregiver. In its main study, about two thirds of treated wounds closed by six months compared with about a quarter of untreated wounds on the same people. Birch triterpenes (Filsuvez) is a gel made from birch bark extract, applied at each dressing change for people aged 6 months and older. In its trial, more wounds closed within 45 days than with a placebo gel, but the difference was smaller and was no longer clear by 90 days. Prademagene zamikeracel (Zevaskyn), for recessive DEB, is made from a person's own skin cells, corrected in a laboratory and grown into sheets that are surgically grafted onto large, long-standing wounds at specialized centers. In its study, most treated wounds healed at least halfway and were less painful at six months, though few closed completely. All three treat wounds; none changes the underlying condition throughout the body. Severe DEB needs a coordinated team. A dietitian and sometimes a feeding tube placed through the abdomen (gastrostomy) help with nutrition and growth. Narrowing of the esophagus is usually treated by stretching it with a balloon, often more than once. Iron, vitamins and sometimes transfusions treat anemia. Occupational and physical therapy help slow finger fusion and joint stiffness, and surgery can release fused fingers, although it often needs repeating. Regular dental care, eye lubricants and attention to bone health and constipation are also part of care.

What to Expect

Life with DEB depends heavily on the type. Many people with dominant DEB have blisters mainly on the hands, feet, knees and elbows, manage their skin with routine precautions such as padding, dressings and careful footwear. Severe recessive DEB is a lifelong, multi-system illness: daily wound care, chronic pain and itch, difficulty eating, anemia and limited hand use can shape a person's routine from infancy, and families often carry a heavy caregiving load. The most serious long-term risk in severe recessive DEB is skin cancer. Chronic wounds and scars can develop an aggressive form of squamous cell carcinoma, usually in young adulthood, and the lifetime risk is more than 90%. These cancers often look like ordinary EB wounds, which is why regular skin examinations by an EB dermatologist are recommended from about age 10 (often every 3 to 6 months in recessive DEB), with biopsy of anything suspicious. Squamous cell carcinoma is the leading cause of death in this form of DEB, so finding it early matters. Ongoing care usually involves an EB specialty center, with routine blood tests for anemia and nutrition, growth checks in children, and monitoring of the heart, bones and other organs in severe disease. Patient organizations such as DEBRA (the Dystrophic Epidermolysis Bullosa Research Association) can help with dressing supplies, education and connecting with other families.

When to Seek Help

See a specialist, ideally at an EB center, for any baby born with blisters or skin that tears easily, or for a child or adult whose skin blisters and scars with minor friction. People with DEB should keep regular follow-up, and someone with recessive DEB should have scheduled skin cancer checks from about age 10. Between visits, contact the care team about a wound that will not heal, one that becomes crusted or more painful than usual, or thick heaped-up scar tissue, since these can be early skin cancer. Contact the team promptly if swallowing becomes harder, meals take longer, food comes back up or drooling increases, because these can signal narrowing of the esophagus. Also call about a wound that looks infected, and about weight loss or a child falling off their growth curve.

Questions to Ask Your Doctor

  1. 1.Do we know whether this is dominant or recessive DEB, and what does the specific gene change suggest about how severe it may become?
  2. 2.Which wound treatments, such as Vyjuvek, Filsuvez or Zevaskyn, make sense for these wounds, and what would treatment involve week to week?
  3. 3.How often should skin cancer checks happen, and which wounds should we point out to you?
  4. 4.What signs of swallowing, nutrition or eye problems should we watch for, and who on the team handles each?
  5. 5.What support, supplies and specialist centers are available, and what does genetic counseling mean for other family members or future pregnancies?

Last reviewed • Oct 2026

Educational content, not medical advice.